What is the equity of TELA Bio this year?
TELA Bio has equity of 18.88 M USD this year.
TELA Bio Equity 2024
TELA Bio Equity
18.88 M USD
TELA Bio Dividend yield
Ticker
TELA
ISIN
US8723811084
WKN
A2PUP9
In 2024, TELA Bio's equity was 18.88 M USD, a 31.94% increase from the 14.31 M USD equity in the previous year.
TELA Bio Aktienanalyse
What does TELA Bio do?
TELA Bio Inc is an American medical technology company that specializes in the development and manufacture of innovative surgical implants. The history of this company began in 2012 when a group of experienced bioengineers and medical professionals decided to develop a better surgical tissue replacement material. The idea was to create a product that not only supports the healing process but is also safe, durable, and easy to handle. Over the years, TELA Bio has successfully implemented the business model of complete vertical integration, which means that the company takes care of everything from research and development to production, distribution, and marketing of its products. This allows the company to build closer relationships with its customers and improve the quality of its products by addressing the needs and requirements of its users. The core business of TELA Bio focuses on a wide range of surgical tissue replacement materials specifically designed for plastic and reconstructive surgery, hernia repair, and wound healing. These products are characterized by their high biocompatibility, strength, and flexibility, and provide a safe and effective solution for a variety of medical applications. Key products offered by TELA Bio include the OviTex® product family, which includes surgical mesh materials for supporting wound healing in hernia repairs and abdominal surgeries, as well as tissue replacement materials for breast reconstruction after mastectomy. These products are known for their high biocompatibility and ability to integrate into the surrounding tissue and restore natural tissue structures. In addition, TELA Bio also offers the TELADERM®-DH product, specifically developed for wound healing in diabetes patients. This product consists of a tissue replacement material that supports skin repair and reduces the risk of infection, particularly in patients with poorly healing wounds. Overall, TELA Bio has developed a wide range of products tailored to the needs of modern medicine. The company is focused on improving the quality of medical care and providing innovative solutions for surgical wound healing. With its successful implementations in research, production, and distribution, TELA Bio is well-positioned to continue growing and solidify its position as a leading provider of medical implants. TELA Bio ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing TELA Bio's Equity
TELA Bio's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding TELA Bio's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating TELA Bio's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
TELA Bio's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in TELA Bio’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about TELA Bio Stock
What was the equity of TELA Bio compared to the previous year?
The equity of TELA Bio has increased/decreased by 31.94% increased compared to the previous year.
What impact does a high equity have on investors of TELA Bio?
A high equity is advantageous for investors of TELA Bio as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of TELA Bio?
A low equity can be a risk for investors of TELA Bio, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of TELA Bio affect the company?
An increase in equity of TELA Bio can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of TELA Bio affect the company?
A reduction in equity of TELA Bio can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of TELA Bio?
Some factors that can affect the equity of TELA Bio include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of TELA Bio so important for investors?
The equity of TELA Bio is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can TELA Bio take to change the equity?
To change equity, TELA Bio can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does TELA Bio pay?
Over the past 12 months, TELA Bio paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, TELA Bio is expected to pay a dividend of 0 USD.
What is the dividend yield of TELA Bio?
The current dividend yield of TELA Bio is .
When does TELA Bio pay dividends?
TELA Bio pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of TELA Bio?
TELA Bio paid dividends every year for the past 0 years.
What is the dividend of TELA Bio?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is TELA Bio located?
TELA Bio is assigned to the 'Health' sector.
Wann musste ich die Aktien von TELA Bio kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of TELA Bio from 5/12/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/12/2024.
When did TELA Bio pay the last dividend?
The last dividend was paid out on 5/12/2024.
What was the dividend of TELA Bio in the year 2023?
In the year 2023, TELA Bio distributed 0 USD as dividends.
In which currency does TELA Bio pay out the dividend?
The dividends of TELA Bio are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von TELA Bio
Our stock analysis for TELA Bio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of TELA Bio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
